SCHEMBL2638486

SCHEMBL2638486

CCCCCCCCCCCC(C)(C)NCCCS(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.44
CA2 P00918 3/20 0.40
CA1 P00915 2/20 0.40
EPHX1 P07099 8/20 0.39
PPARA Q07869 2/20 0.38
S1PR1 P21453 1/20 0.36
GGPS1 O95749 1/20 0.34
CA12 O43570 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
FDPS P14324 2/20 0.33
CASP2 P42575 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15154746 1.00 EPHX2 (0.44) EPHX2CA2CA1EPHX1PPARA
SCHEMBL25273674 1.00 EPHX2 (0.44) EPHX2CA2CA1EPHX1PPARA
SCHEMBL15264198 1.00 EPHX2 (0.44) EPHX2CA2CA1EPHX1PPARA
Water SCHEMBL16395781 0.98 EPHX2 (0.43) EPHX2CA2CA1EPHX1PPARA
Water SCHEMBL6242366 0.98 EPHX2 (0.43) EPHX2CA2CA1EPHX1PPARA
Water SCHEMBL16395987 0.95 EPHX2 (0.47) EPHX2CA2CA1EPHX1PPARA
SCHEMBL10232056 0.93 EPHX2 (0.40) EPHX2CA2CA1EPHX1PPARA
SCHEMBL8504724 0.90 EPHX2 (0.43) EPHX2CA2CA1EPHX1PPARA
SCHEMBL11505829 0.88 EPHX2 (0.42) EPHX2CA2CA1EPHX1S1PR1
SCHEMBL11504761 0.88 EPHX2 (0.42) EPHX2CA2CA1EPHX1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532168-B1 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GLAXOSMITHKLINE BIOLOG SA (BE) 2014-07-23 EP claimed
JP-4652808-B2 2011-03-16 JP claimed
US-20100291137-A1 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2010-11-18 US claimed
EP-1572729-B1 MUTANT FRPB PROTEIN AND REFOLDING METHOD GLAXOSMITHKLINE BIOLOG SA (BE) 2010-09-22 EP claimed
US-20080025993-A1 Method for Refolding Neisserial Nspa Protein GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2008-01-31 US claimed
US-20060141563-A1 Mutant protein and refolding method GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) 2006-06-29 US claimed
JP-2006511463-A 2006-04-06 JP claimed
EP-1572729-A2 MUTANT PROTEIN AND REFOLDING METHOD GlaxoSmithKline Biologicals S.A. (BE) 2005-09-14 EP claimed
EP-1532168-A2 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GlaxoSmithKline Biologicals S.A. (BE) 2005-05-25 EP claimed
WO-2004020463-A2 MUTANT PROTEIN AND REFOLDING METHOD GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2004-03-11 WO claimed
WO-2004020452-A2 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2004-03-11 WO claimed
US-5900386-A GROUP IB OR 8 METALS ON SUPPORT DEGUSSA AKTIENGESELLSCHAFT (DE) 1999-05-04 US claimed
EP-0841566-A1 Positive control plasma for lupus anticoagulant Pentapharm A.G. (CH) 1998-05-13 EP claimed
EP-1532168-B1 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GLAXOSMITHKLINE BIOLOG SA (BE) 2014-07-23 EP disclosed
US-20100291137-A1 METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN GLAXOSMITHKLINE BIOLOGICALS SA (BE) 2010-11-18 US disclosed
EP-1572729-B1 MUTANT FRPB PROTEIN AND REFOLDING METHOD GLAXOSMITHKLINE BIOLOG SA (BE) 2010-09-22 EP disclosed
US-5620584-A Electrochemical reduction of metal salts as a method of preparing highly dispersed metal colloids and substrate fixed metal clusters by electrochemical reduction of metal salts STUDIENGESELLSCHAFT KOHLE MBH (DE) 1997-04-15 US disclosed
WO-1997012952-A1 LAUNDRY DETERGENT COMPOSITION UNILEVER PLC (GB) 1997-04-10 WO disclosed
EP-0672765-A1 Electrochemical reduction of metal salts as a method of preparing highly dispersed metal colloids and substrate fixed metal clusters by electrochemical reduction of metal salts Studiengesellschaft Kohle mbH (DE) 1995-09-20 EP disclosed
US-5403505-A An antiseptic concentrate solution comprising a polyamides or polyamideether copolymers, a quaternary ammonium, a phenol, a biguanide and a quaternary phosphonium compounds; stability, water solubility; microbiocides HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1995-04-04 US disclosed